Brian Lawler

Brian Lawler

brian-lawler

Recent articles





Less Is More for Vertex

The company's potential hepatitis C compound proves effective with fewer dosages.








Busy Day for MannKind

It unveils a brand name, a partnership, and new data for its lead drug.


Pfizer Puts Safety First

Increased FDA scrutiny may motivate the pharmaceutical's new drug-safety site.